234 related articles for article (PubMed ID: 21227898)
1. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
[TBL] [Abstract][Full Text] [Related]
2. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
[TBL] [Abstract][Full Text] [Related]
5. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
[TBL] [Abstract][Full Text] [Related]
7. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
[TBL] [Abstract][Full Text] [Related]
8. Study of cytokines in ulcerative colitis.
Funakoshi K; Sugimura K; Sasakawa T; Bannai H; Anezaki K; Ishizuka K; Yoshida K; Narisawa R; Asakura H
J Gastroenterol; 1995 Nov; 30 Suppl 8():61-3. PubMed ID: 8563893
[TBL] [Abstract][Full Text] [Related]
9. Bioactive IL-18 expression is up-regulated in Crohn's disease.
Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
[TBL] [Abstract][Full Text] [Related]
10. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
Krajina T; Leithäuser F; Möller P; Trobonjaca Z; Reimann J
Eur J Immunol; 2003 Apr; 33(4):1073-83. PubMed ID: 12672074
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of interleukin 17 in inflammatory bowel disease.
Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.
Melgar S; Yeung MM; Bas A; Forsberg G; Suhr O; Oberg A; Hammarstrom S; Danielsson A; Hammarstrom ML
Clin Exp Immunol; 2003 Oct; 134(1):127-37. PubMed ID: 12974765
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
McAlindon ME; Hawkey CJ; Mahida YR
Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
[TBL] [Abstract][Full Text] [Related]
14. miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5.
Yao J; Gao R; Luo M; Li D; Guo L; Yu Z; Xiong F; Wei C; Wu B; Xu Z; Zhang D; Wang J; Wang L
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211804
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease.
Camoglio L; Te Velde AA; Tigges AJ; Das PK; Van Deventer SJ
Inflamm Bowel Dis; 1998 Nov; 4(4):285-90. PubMed ID: 9836081
[TBL] [Abstract][Full Text] [Related]
16. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
Nielsen OH; Rüdiger N; Gaustadnes M; Horn T
Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176
[TBL] [Abstract][Full Text] [Related]
17. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
[TBL] [Abstract][Full Text] [Related]
18. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.
Liu Z; Geboes K; Colpaert S; D'Haens GR; Rutgeerts P; Ceuppens JL
J Immunol; 2000 Apr; 164(7):3608-15. PubMed ID: 10725717
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of IL-16 in inflammatory bowel disease.
Seegert D; Rosenstiel P; Pfahler H; Pfefferkorn P; Nikolaus S; Schreiber S
Gut; 2001 Mar; 48(3):326-32. PubMed ID: 11171821
[TBL] [Abstract][Full Text] [Related]
20. Increased synthesis and intestinal expression of IL-39 in patients with inflammatory bowel disease.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Barreto-Zúñiga R; Martínez-Benítez B; Yamamoto-Furusho JK
Immunol Res; 2024 Apr; 72(2):284-292. PubMed ID: 37968544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
